It remains to be seen as to whether there is grounds for legal intervention on behalf of shareholders,
The next steps Vast biosciences makes will be watched with interest as will the various connections between the various players
do not advertise external blogs/2015/07/07/alchemia-has-a-vast-problem/
R&D tax incentive, page-26
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable